EO-2000 series

N/A

Report date: 2025/03/20 15:27:31
NME

Base Information

Drug NameEO-2000 series
Drug Alias NameKT-2000 seriesPARP inhibitors (NewGen Therapeutics/Rakovina Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNewGLab Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesNewGLab TherapeuticsRakovina Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsOvarian Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A